Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 3
Review
Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,362 | Dovepress* | 9,403+ | 1,958 | 11,361 | |
| PubMed Central* | 2,959 | 1,139 | 4,098 | ||
| Totals | 12,362 | 3,097 | 15,459 | ||
| *Since 21 September 2016 | |||||
View citations on PubMed Central and Google Scholar